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Luminal accumulation of viscous, poorly hydrated, and less transportable mucus has been associated with
altered mucus rheology and reduced mucociliary clearance. These symptoms are some of the cardinal
clinicalmanifestationsfoundthroughoutmajorrespiratorydiseasesaswellasgastrointestinalanddigestive
disorders. Applications of current mucolytics may yield short-term improvements but are continuously
challenged by undesirable side-effects. While nanoparticles (NPs) can interact with mucin polymers,
whether functionalized NPs can rectify mucus rheology is unknown. Herein, we report that
carboxyl-functionalized NPs (24 nm and 120 nm) dramatically reduced mucin gel size and accelerated
mucin matrix hydration rate (diffusivity). Our results suggest that carboxyl-functionalized NPs disperse
mucin gels possibly by enhancing network hydration. This report highlights the prospective usages of
carboxyl-functionalizedNPsasanovelmucusdispersantormucolyticagentinadjustingmucusrheological
properties and improving mucociliary transport to relieve clinical symptoms of patients suffering from
relevant diseases.
M
ucin, a seemingly unimportant and inert biopolymer, is omnipresent throughout the lumen of various
organsandalmostalltheepithelialmucosa
1,2.Itsprevalencesuggestsmorecomplexfunctionsthanwhat
its passive appearance originally portrays. Particularly in humans, mucin gels have been shown to serve
as an innate immune defense by trapping bacteria, viruses and hazardous particulates
1–3. Overall, mucins play
critical roles in maintaining the health and integrity of multiple structures such as, but not limited to, the
respiratory, digestive, visual and reproductive systems
1,2,4,5. To perform these protective tasks, a pivotal balance
between mucin secretion and its rheological properties must be maintained in order to complement the effective
mucociliary clearance
6–8. Since exocytotic process and rheological properties of mucin are tightly regulated by
physiological stimulations, any disturbance to this homeostatic control ultimately leads to the dysfunction and
demise of biological systems
6,9,10.
Inmanyinflammatorydiseases,unregulatedmucinreleasepredisposestothepresenceofpoorlytransportable
andhighlyviscousmucus,lumenocclusion,andchronicbacterialinfection
3,6,11.Thesepathologicalconditionsare
thecommonclinicalmanifestationstypicallyobservedinpulmonaryandgastrointestinalmorbidity
11,12.Inmajor
respiratory diseases encompassing chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), asthma,
bronchiectasis, and pneumonia, the inundating amount of abnormally viscous and dehydrated mucus can
obstruct airway passages
3,11,13. Blockage of bronchial trees reduces ventilation, hampers mucociliary clearance,
and cultivates pathogenic microbial expansion and re-infection
11,13. In order to break this relapsing cycle, the
viscosityofpulmonarysecretionmustbereducedtohelprestoremucociliarytransport.Variousspecificandnon-
specific mucolytic aerosols have been considered
13–15. For peptide mucolytics, trypsin has been utilized exten-
sively.Itisaserineproteasethatcutsthepeptidelinksintheapomucincomponent
15.However,majordrawbacks
involve the incision at many serine sites of unspecific peptides and side-effects that include fever, hoarseness,
irritation of the mouth, nausea and vomiting
15. Clinical usages of dornase and streptodornase were successful at
liquefying secretion by degrading the nucleic acid component of mucus
15. Nonetheless, both enzymes are
expensive, have a short half-life and have been reported to cause sensitivity in patients
15. Classical mucolytics,
such asN-acetylcysteine (NAC)or Nacystelyn, depolymerize the mucin biopolymerby hydrolyzing the disulfide
bonds linking the mucin monomers
14–16. Unfortunately, sulfurous odor and a pH of 2.2 are associated with
bronchospasm for these drugs
16. In addition, definitive evidence demonstrating that NAC and similar com-
pounds can effectively improve mucus clearance is still lacking
14,17. Other non-destructive mucolytics have been
proposed to untangle mucin polymer chains by charge shielding
16. Such agents include low molecular dextran
sulfate, heparinandother glycoproteins
16,18.Ingeneral, althoughmanyaerosolized mucolyticsmay havedemon-
strated the potential for improving mucus rheology, they can possibly over-liquefy mucus secretion resulting in
impaired clearance
19.
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thick mucus has led to limited rectification on altered mucus rhe-
ology. The mucin polymer networks of mucus have a characteristic
tangled topology
1,20. Since the rheological properties of mucus are
governed mainly by the tangled density of mucin polymers, which
decreases with the square of the volume of the mucin matrix, the
mucin network hydration (degree of swelling) is the most critical
factor in determining the rheological properties of mucus
1,9. Aside
from the traditional ineffective expectorants, an approach that can
directly promote mucin matrix hydration and disperse aggregated
mucin gels has not been explored.
WehavepreviouslydemonstratedthatpositivelychargedNPscan
directly alter the viscoelastic property of mucus by hindering the
mucin network swelling rate and aggregating mucin polymers
21.
Nonetheless, whether negatively-charged NPs can restore defective
mucinhydrationanddisperseaggregatedmucingelshasnever,here-
tofore, been conceived. In this study, our investigation examined the
use of NPs with negatively-charged surface modifications to rectify
altered mucus rheological properties. The concentration range of
NPs used in this investigation was within the level found in multiple
drug delivery systems
22,23. Our results provide the first evidence that
negatively-charged NPs may serve as a potential decongestant/
non-destructive mucolytic agent to reduce mucus accumulation
and associated bacterial infections commonly found with various
diseases.
Results
Carboxyl-functionalized NP characterization. Dynamic laser scat-
tering (DLS) was used to characterize the carboxyl-functionalized
polystyrene NPs. The particle size distribution for 120 nm and
24 nm NPs ranged from ,70 to 150 nm and ,10 to 50 nm,
correspondingly. The predominant size for each was 114 or 23 nm
(Fig. 1 A and B).
Carboxyl-functionalized NPs disperse aggregated mucus. To
support the notion that negatively-charged NPs can affect mucin
rheological properties, we examined the effect of NPs on dis-
persing mucin gels. Porcine gastric mucin (1 mg/L) was prepared
in Hanks’ solution (with 8.2 mM Ca
21 at pH 7.4) and was equi-
librated for $48 hrs until significant aggregation of mucus masses
of approximately 8 mm in diameter were attained. The 8.2 mM Ca
21
was an experimental condition used to gelate dilute mucin solution
forstudyingthe dispersioncapacity of NPs. On additionof carboxyl-
functionalized NPs, size change in aggregated mucus gel particles
was monitored with dynamic laser scattering (DLS) after 1, 3, 5, and
24 hrs. Figures 2A and B demonstrate that carboxyl-functionalized
NPs dispersed and drastically decreased the mucin aggregate size
at 1 mg/L, 0.5 mg/L and 0.1 mg/L. Using 120 nm NPs, 1 mg/L sig-
nificantly reduced mucus gel size from ,8 mmt o,300–500 nm
throughout 24 hr. A similar trend in mucin gel size reduction
(from ,8 mmt o,200–300 nm) was observed with 24 nm NPs.
In comparison to the mucin-only control (NP free), mucin aggre-
gated gel size remained consistent at ,8 mm throughout 24 hrs.
Figures 2A and B illustrate that both 24 nm and 120 nm NPs
lowered mucin gel size as a function of increasing NP concen-
tration from 0.1–1 mg/L. In addition, a NP size-dependent effect
was observed where 24 nm NP minimized mucin aggregation
size more efficiently than 120 nm NP at the corresponding time
points. NP-only control (mucin-free) further revealed insignifi-
cant change in NP size throughout 24 hrs (Fig. 2A and B).
Therefore, the reduced gel size is the result of partially dispersed
mucin gels rather than self-aggregation of NPs in Ca
21 rich
solution.
Carboxyl-functionalized NPs accelerate mucin matrix expansion.
We then undertook showing that negatively-charged NPs could
enhance the mucin matrix hydration by utilizing an in vitro mucin
swellingkineticsfunctionalassay(seemethods).Forproofofconcept
purpose, only 120 nm NPs were investigated for its effects on mucin
network hydration. A representative plot comparing the swelling
kinetics of newly exocytosed mucin matrices between the control
(NP free) and 120 nm carboxyl-functionalized NP treatment is
shown in Figure 3. The rate of mucin network swelling (hydration)
was significantly elevated in the presence of carboxyl-functionalized
NP. The increase in mucin swelling rate was also NP concentration
Figure 1 | Carboxyl-functionalized NP characterization. DLS assessment
of carboxyl-functionalized NPs in Hanks’ solution showed a size
distribution of ,70 to 150 nm for 120 nm while 24 nm NPs had a
distribution of ,10 to 51 nm.
Figure 2 | Carboxyl-functionalized NPs disperse mucin gel aggregation. Negatively-charged NPs of (A) 120 nm (n$6) and (B) 24 nm (n$6)
significantly reduced sizes of aggregated mucus masses from ,8 mm to below 3 mm in 24 hrs of incubation. Various concentrations (red solid triangles:
0.1 mg/L,bluesolidrhombus: 0.5 mg/L, green solidtriangles:1 mg/L) of negatively-chargedNPs (120 and24 nm) wereadded to mucin solution(1 mg/L).
White open circles represent sizes of (A) 120 nm (1 mg/L) and (B) 24 nm (1 mg/L) NPs per se (n$6) throughout 24 hrs. No significant self-clumping
was observed. Black solid squares represent sizes of mucin aggregates (1 mg/L; mucin control, n$6) throughout 72 hrs. The sizes of mucin aggregates
were determined with DLS as described previously
9,21.
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similar results (Fig. 4).
Carboxyl-functionalized NPs markedly enhances secreted mucin
diffusivity. Exocytosis of mucin granules from cultured A549 cells
was stimulated with 1 mM ionomycin and mucin diffusivity was
calculated from the swelling kinetics as described (see methods).
Compared to the mucin only controls in NP free Hanks’ medium,
negatively-charged functionalized NPs (120 nm) accelerated mucin
diffusivity by approximately ,2, 2.4 and 3.3 folds at 0.1, 0.5 and
1 mg/L, correspondingly. Elevation in mucin diffusivity also showed
NP concentration dependency. A faster mucin gel swelling rate
indicates greater mucin diffusivity and a less viscous gel
4. Our data
indicates that negatively-charged NPs can expedite mucin hydration
rate and diffusivity, possibly reducing mucus viscosity and helping
restore functional mucociliary activity.
Discussion
Mucin gels are secreted by epithelial mucosa of many organs includ-
ing vaginal tract, eyes, gastrointestinal wall, and pulmonary lumen
5.
At optimal rheological properties, mucin gel and mucociliary action
orchestrate in unison to remove pathogenic microbes and harmful
substances
1,6,11,14. However, when the balance between mucus pro-
duction, hydration and transportation is perturbed, a series of path-
ological manifestations ensue ramifying into devastating outcomes.
Especially in respiratory diseases, the accumulation of excessive
amountsofhighlyviscousmucusintracheobronchialtreescancause
atelectasis, difficulty in expectoration, cease mucociliary clearance,
obstruct airflow, and increase susceptibility to infection
11,13,15,16.
Furthermore, many GI disorders characterized by luminal occlusion
with adherent mucus, has led to insufficient release of digestive
enzymes, internal calcification and malnutrition. For example, the
inspissated mucus can obstruct pancreatic ducts, biliary trees, and
smallintestineresultinginseriousmalnutrition,aswellaspancreatic
endocrine and exocrine dysfunction in CF patients
12,15,24–26.
In order to alleviate the symptoms and the persistent cause of
mucus associated diseases, liquefaction of the inspissated secretion
is highly desirable in the debilitated patients
15. Attempts to mobilize
stagnant mucus have yielded facilitative approaches but are none-
theless unsuccessful
14. Many current therapies are accompanied by
concomitant side-effects. It has been reported that usage of some
predominant mucolytic agents, i.e. deoxyribonuclease and N-acetyl
cysteine, results in immediate liquefication of bronchial mucin
15,27.
Thequickdisassemblyofmucinnetworkinstigated adrowningphe-
nomenon where the patients were unable to expectorate a large
amount of fluid efficiently
15,16. Therefore, a new approach to effi-
ciently (1) disperse existing aggregated mucus and (2)hydrate newly
released mucin matrices without denaturing the mucin network to a
monomeric structure is needed. We have previously demonstrated
that positively charged-functionalized NPs (-NH2) can alter the
rheological properties of mucin network polymers by electrostatic
interactions. These polycationic NPs significantly promoted mucin
aggregation and reduced mucin gel swelling rate via acting as pos-
sible crosslinkers for polyanionic mucin matrices
21. Under the cur-
rent investigation, we tested whether negatively-charged modified
NPs can help restore mucin rheological properties by dispersing
aggregated mucin gels and accelerating polymer network hydration.
To examine if aggregated mucin can be dispersed by negatively
charged-functionalized NPs, gastric mucin was used as a model in
our study as it shares many similarities with its airway counter-
part
28–30. Our method is supported by previous studies that also used
gastric mucin as a model system to examine the viscoelastic pro-
perties of mucins
31–36, since there is currently no commercial mucin
sample available that can be preserved in the native state. DLS was
implemented to examine the dispersing interactions between func-
tionalized NPs and aggregated mucin. This technique allows mucin
structure and dynamicsto becontinuously probedin the nativestate
without chemical fixation and denaturation, which minimizes arti-
facts
1,2. By measuring Brownian motion of mucin polymers, the
diffusion constant can be calculated which is inversely proportional
to the hydrodynamic diameter of the measured particle. A high
diffusion constant usually correlates with small mucin gelation/
aggregation
1,2. To prove that carboxyl-functionalized NPs can dis-
perse aggregated mucin gel, NPs were added to the mucin solution
with gel size of approximately 8 mm. As demonstrated by Figure 2A,
120 nm negatively-charged NPs decreased the size of mucin
aggregation by ,1.9, 2.5 and 28 folds at corresponding 0.1, 0.5 and
1 mg/L after the 1
st hr. On the other hand, smaller NPs (24 nm)
reduced mucin aggregation size by ,3, 4 and 30 folds after 1
st hr
atthecorrespondingconcentrationsshownabove(Fig.2B).Ourdata
suggests that negatively-charged NPs can disperse mucin aggregates
in both concentration and size-dependent manners. The mechan-
isms may involve electrostatic repulsion between negatively-charged
NPsandthepolyanionicsitesonmucinsuchasthesialic,sulfateand
carboxyl functional groups, promoting mucin disaggregation
1,2.
Another possible mechanism could be attributed to the chelation
Figure 3 | Effects of carboxyl-functionalized NPs on hydration rate of
mucinmatricessecretedfromA549cells. Arepresentativeplotofswelling
kinetics(hydrationrate)ofmucinmatricessecretedbyA549cellsisshown
here. Data points were fitted with the characteristic first order kinetic
equation (see Materials and methods). Exocytosis was triggered by
ionomycin. Four representative lines are displayed here. The control (NP
free; open circles) shows a lower mucin network swelling rate than the
swellingrateofmucinmatrixwhenexposedto120 nmnegatively-charged
NPs (0.1 mg/L open triangles, 0.5 mg/L solid squares and 1 mg/L solid
circles).
Figure 4 | Carboxyl-functionalized NPs enhance mucin diffusivity
secreted from A549 cells. Mucin diffusivity was significantly elevated
by negatively-charged NPs (120 nm) as a function of increasing NP
concentration. Data are shown as mean6SD (n$10). NP treated groups
are markedly different from the untreated control at p,0.005 as indicated
by **.
www.nature.com/scientificreports
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21) by negatively-
charged NPs
1. Alternatively, akin to the sugar derivative-based
mucolytic agents i.e. dextran, the polyanionic surface charges may
reduce the cross-link density of sputum
37. The polyanionic func-
tional groups on NPs may disrupt hydrogen bonds between mucin
polymers, and compete for hydrogen bonding sites with mucin
glycoproteins, lowering intra/inter-network cross-links and inter-
actions
18,37,38. Consequently, the new hydrogen bonds may be
inconducive to the overall structural integrity and rheological
properties
18,37,38. Finally, smaller NPs can more effectively disperse
mucin gels possibly by the differential charge densities
39. Our find-
ings are supported by other studies showing that negatively-charged
NPs were repelling/not adhering to polyanionic mucus gels
40. The
combinatory attributes from electrostatic repulsion, chelation and
reduction in intra/inter-mucin hydrogen bonding density may allow
mucociliary transport of mucus and coughing mechanism to take
place.
Beside physical disaggregation, another vital method to reduce
viscoelasticity is by hydrating mucus. According to Sheehan and
Verdugo, the mucin polymer network of mucus has a characteristic
tangled topology
20. The mucin polymer tangled density determines
the rheological properties of mucus, whichdecreases with the square
ofthevolumeofthemucinmatrix.Hence,mucinnetworkhydration
(degree of swelling) critically governs the mucus viscoelastic prop-
erties
1. Measurement of mucin network hydration rate (diffusivity)
provides a direct assessment of changes in mucin rheological prop-
erties (viscosity) released from living cells. Results from dispersing
aggregated mucin gels suggest that negatively-charged functiona-
lized NPs play a critical role in decondensation of mucin granules,
but proof awaits a direct evidence of their effects on native mucin
rheological properties. We tested whether negatively-charged NPs
can directly accelerate mucin hydration rate by measuring the swell-
ing kinetics of newly exocytosed matrices from human lung A549
cells. A549 cells are a representative in vitro model system for study-
ing mucin swelling kinetics as they express both major respiratory
MUC5ACandMUC5Bmucinproteins
41,42.Ourresultsshowedthat
negatively-chargedNPsacceleratedmucinnetworkhydrationwhich
we postulate would render it more transportable (Fig. 3). Moreover,
enhanced mucin diffusivity in a NP concentration-dependent man-
ner is correlated with lower viscosity and less obstruction (Fig. 4).
Our experimental evidence further suggests that in chronic diseases
involvingmucushypersecretion,obstructionandincreasedviscosity,
negatively-charged functionalized NPs may serve as effective mucus
decongestants and dispersants.
Methods
Nanoparticle characterization. Carboxyl-functionalized polystyrene NPs with
various sizes(i.e.24 nmand120 nm)and concentrations(i.e.1 mg/L, 0.5 mg/L, and
0.1 mg/L)(BangsLaboratories,Fishers, IN,USA) were usedin ourstudy. The24 nm
NPs have a surface charge of 180 meq/g, parking area of 217.5 sq.A ˚/group and
1.06 g/cm
3 while 120 nm NPs have a surface charge of 171 meq/g, parking area of
45.8 sq.A ˚/group and 1.06 g/cm
3 (based on manufacturer information). All NPs have
a size standard deviation of #10% (based on manufacturer information). These sizes
were independently confirmed using homodyne dynamics laser scattering. All NP
samples were sonicated before usage.
Mucin particulate sizing using dynamic laser scattering. The dispersion of
aggregated mucin mass was monitored by measuring particle size using homodyne
dynamics laser scattering (DLS). Samples of porcine gastric mucin at 1 mg/L
(Lot# 018K0079, Sigma-Aldrich, MO, USA) were prepared with Hanks’ solution
containing 1.2 mM Ca
21, 20 mM Tris-HCl (tris(hydroxymethyl)aminomethane
hydrochloride) and 10 mM MES (2-(N-morpholino)ethanesulfonic acid) (Sigma-
Aldrich,MO,USA) tobufferthe pHaround7.3
9.Thesolutionwasthoroughlymixed
until mucin was dissolved. Aliquots of mucin samples (10 ml) were directly filtered
dropwisethrougha0.2-mmMilliporeSFCAmembrane(pre-washedwith0.1 NHCl)
(Fisher Scientific, CA, USA) into clean scintillation vials. Each vial was then treated
with 7 mM of filtered Calcium chloride dihydrate (Sigma-Aldrich, MO, USA)
solution prepared with distilled H2O. The scintillation vials were positioned in the
goniometer of a Brookhaven laser spectrometer (Brookhaven Instruments, NY,
USA). Mucin gel aggregation was allowed to take place by equilibrating for 48 hrs.
They were subsequently analyzed by detecting the scattering fluctuations at a
45-degree scattering angle. Commercialized polystyrene NPs (Bangs Laboratories,
Fishers, IN) with dimensions of 24 and 120 nm were added to mucin samples.
Changes in mucin particulate dimension triggered by three negatively-charged NP
concentrations(-COOH,24and120 nm)(i.e.1 mg/L,0.5 mg/L,and0.1 mg/L)were
measured. All NPs were prepared in distilled H2O. Filtered NP suspension, added to
scintillation vials, was tested for its ability to disperse aggregated mucin gel and was
monitored 1 hr, 3 hrs, 5 hrs, and 24 hrs. Self-aggregation induced by NP-only
control was monitored at 0 hr, 3 hrs, 5 hrs and 24 hrs. Mucin-only control was
examined48 hrsinadvanceand24 hrsafterreachingmaximumaggregatedsize.The
autocorrelation function of the scattering intensity fluctuations was averaged over a
2-min sampling time using a Brookhaven BI 9000AT autocorrelator. Particle size
distribution was calculated by CONTIN
43. Calibration was conducted with standard
monodisperse suspensions of latex microspheres ranging from 50 nm to 10 mm
(Polysciences, PA, USA).
A549 cell culture. The human lung carcinoma cell line A549 was obtained from
American Type Culture Collection (ATCC, Manassas, VA). The A549 cell line is an
airway alveolar epithelial cell line commonly used as a secretory model
9,44. Cells were
cultured in 15 cm cell culture plates (VWR, Brisbane, CA) containing F-12 nutrient
mixture medium (Invitrogen, Carlsbad, CA) supplemented with 100 U of penicillin/
streptomycin (Invitrogen, Carlsbad, CA) and 10% heat-inactivated fetal bovine
serum (FBS) (Invitrogen, Carlsbad, CA). The A549 lung cells were cultured in 15 cm
falcon plates and incubated in a humidified incubator at 37uC/5% CO2. Cell counts
wereperformedusingtrypanblue(Sigma,St.Louis,MO)exclusionandaBright-Line
haemocytometer.
Swelling kinetics and A549 cell preparation. The culture plates were rinsed with
Hanks’ buffer twice. Non-trypsin dissociation buffer (Invitrogen, Carlsbad, CA) was
added to detach cells from plates and subsequently incubated at 37uC for 15 min,
centrifuged at 700 rpm for 5 min, and resuspended in Hanks’ buffer (Invitrogen,
Carlsbad, CA). Resuspended cells were dispersed into MatTek glass bottom dishes
(MatTekCorporation,Ashland,MA)andequilibratedina37uCincubatorfor10 min
prior to adding varying concentrations of carboxyl-functionalized NPs. Both Hanks’
solution and NP suspension were buffered with Tris-HCl and MES (Sigma, St. Louis,
MO) to pH 7.4. The pH was monitored and maintained at approximately 7.4
throughout the experiments
9,21.
A549cellswereviewedandvideo-recordedwithphase-contrastlensusingaNikon
Eclipse TE-2000-U inverted fluorescence microscope (Nikon Eclipse TE-2000 U,
Tokyo, Japan). Degranulation of A549 cells was induced by 1 mM ionomycin (Sigma,
St. Louis, MO) and was found to be a readily observable discrete quantal process.
DuringexocytosisintoextracellularHanks’solution,releasedgranulesundergorapid
swelling. Video-recordings of granular exocytosis and swelling were captured at 30
frames s
21. The analysis of the changing mucin matrix dimension was assessed with
NIS-Elements software (Nikon, Melville, New York)
9,21.
Measurements of the radii of the released mucin matrices, as a function of time,
were used to verify that the swelling of the secreted material followed the character-
istic features of polymer gel swelling kinetics
9,21. The swelling of a polymer follows a
typicaldiffusivekineticsthatisindependentofthesize,internaltopology,orchemical
composition of the gel
9,21. For spherical gels, as observed from the exocytosed mucin
granules of A549 cells, the radial dimension increased following a characteristic first
order kinetics of the form r(t)5rf–(rf–ri)e
–t/t, where ri and rf are the initial and final
radiusofthegranulematrix,respectively,andtisthecharacteristicrelaxationtimeof
the swelling process
1. The polymer network of gels diffuses into the solvent (Hanks’
solution), with diffusivity (D) (D5(rf)
2/t [cm
2 s
–1]). The diffusivity (D) of polyionic
gels varies with the concentration of counterions in the swelling medium. In this
study, we measured the swelling kinetics of exocytosed mucin gels in Hanks’ buffer
(Invitrogen, Carlsbad, CA) with NP concentrations ranging from 0.1–1 mg/L.
Previous reports have predicted that polymer viscosity is proportional to the
molecularweightofpolymersandthatpolymerdiffusivityisinverselyproportionalto
the molecular weight. Therefore, polymer viscosity and diffusivity are inversely
proportional toeach other
45,46.Higher polymer diffusivity indicateslowerviscosity of
polymers. Thus, we can take direct measurements of changes in mucin diffusivity
under different NP concentrations as changes in mucin viscosity.
Statistical analysis. Data was presented as means 6 SD. Each experiment was
performed independently at least three times. Statistical significance was determined
using a Student’s t-test analysis with p values of ,0.005 (Microsoft Excel and
GraphPad Prism 4.0, GraphPad Software, Inc., San Diego, CA).
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